Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn’s Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany

Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn’s Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany

Introduction: Infliximab (IFX) therapy is efficacious for inducing and maintaining symptomatic remission in patients with Crohn’s disease (CD), but whether this benefit results in reduced hospitalization rates and therefore may improve patients’ quality of life in an economically sensible way is con...

Full description

Bibliographic Details
Main Authors: Niels Teich, Michael Bläker, Frank Holtkamp-Endemann, Eric Jörgensen, Andreas Stallmach, Susanne Hohenberger
Format: Article
Language:English
Published: Karger Publishers 2020-12-01
Series:Inflammatory Intestinal Diseases
Subjects:
crohn’s disease
infliximab
hospitalization rate
work productivity/activity impairment
health-related quality of life
Online Access:https://www.karger.com/Article/FullText/512159

Internet

https://www.karger.com/Article/FullText/512159

Similar Items